Literature DB >> 17855701

Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.

Lorelei A Mucci1, Paul W Dickman, Mats Lambe, Hans-Olov Adami, Dimitrios Trichopoulos, Tomas Riman, Chung-Cheng Hsieh, Sven Cnattingius.   

Abstract

BACKGROUND: Pregnancy influences subsequent maternal ovarian cancer risk. To date, there is limited evidence whether two characteristics of pregnancy, gestational age and birth weight, could modify risk.
MATERIALS AND METHODS: We studied 1.1 million Swedish women who delivered singleton births between 1973 and 2001. Information on infant gestational age and birth weight was abstracted from the nationwide Swedish Birth Register. Women were followed prospectively through linkage with other population-based registers for occurrence of ovarian cancer, death, or emigration through 2001. Hazard ratios [relative risk (RR), 95% confidence interval (95% CI)] from Cox models were used to estimate associations between gestational age, birth weight, and epithelial ovarian cancer risk.
RESULTS: During 12.6 million person-years, 1,017 epithelial ovarian cancers occurred. Mean age at diagnosis was 43 years. Compared with women with term deliveries (>/=40 weeks), women with moderately (35-36 weeks) or very (<35 weeks) preterm deliveries had increased risks of epithelial ovarian cancer (RR 1.4, 95% CI 1.0-2.0 and RR 2.3, 95% CI 1.3-3.8, respectively). In contrast, women giving birth to small-for-gestational-age babies had a reduced risk (RR 0.7, 95% CI 0.4-1.0). Stratifying on birth weight and gestational age, there was a strong protective effect of low birth weight on maternal risk of epithelial ovarian cancer among term deliveries, whereas birth weight seemed to have little effect among preterm births (P(interaction) = 0.022).
CONCLUSIONS: Our results lend further support that the hormonal milieu of a pregnancy may modify long-term risk of developing ovarian cancer. 32).

Entities:  

Mesh:

Year:  2007        PMID: 17855701      PMCID: PMC2646123          DOI: 10.1158/1055-9965.EPI-06-0962

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  38 in total

1.  Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis.

Authors:  Peter G McGovern; Amaury J Llorens; Joan H Skurnick; Gerson Weiss; Laura T Goldsmith
Journal:  Fertil Steril       Date:  2004-12       Impact factor: 7.329

Review 2.  Impact of medically assisted fertility on preterm birth.

Authors:  M Filicori; G E Cognigni; E Gamberini; E Troilo; L Parmegiani; S Bernardi
Journal:  BJOG       Date:  2005-03       Impact factor: 6.531

Review 3.  Polycystic ovary syndrome and gynecological cancers: is there a link?

Authors:  Angiolo Gadducci; Antonio Gargini; Elisabetta Palla; Antonio Fanucchi; Andrea Riccardo Genazzani
Journal:  Gynecol Endocrinol       Date:  2005-04       Impact factor: 2.260

4.  Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.

Authors:  M A Riopel; B M Ronnett; R J Kurman
Journal:  Am J Surg Pathol       Date:  1999-06       Impact factor: 6.394

5.  Histologic types of epithelial ovarian cancer: have they different risk factors?

Authors:  Allison W Kurian; Raymond R Balise; Valerie McGuire; Alice S Whittemore
Journal:  Gynecol Oncol       Date:  2005-02       Impact factor: 5.482

6.  Birth weight in offspring of mothers with polycystic ovarian syndrome.

Authors:  Teresa Sir-Petermann; Catalina Hitchsfeld; Manuel Maliqueo; Ethel Codner; Bárbara Echiburú; Raimundo Gazitúa; Sergio Recabarren; Fernando Cassorla
Journal:  Hum Reprod       Date:  2005-03-31       Impact factor: 6.918

7.  Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling.

Authors:  Luigi Laviola; Sebastio Perrini; Gaetana Belsanti; Annalisa Natalicchio; Carmela Montrone; Anna Leonardini; Antonella Vimercati; Marco Scioscia; Luigi Selvaggi; Riccardo Giorgino; Pantaleo Greco; Francesco Giorgino
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

8.  Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction.

Authors:  Sofía P Salas; Guillermo Marshall; Blanca L Gutiérrez; Pedro Rosso
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

9.  Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome.

Authors:  S Weerakiet; C Srisombut; A Rojanasakul; P Panburana; A Thakkinstian; Y Herabutya
Journal:  Gynecol Endocrinol       Date:  2004-09       Impact factor: 2.260

Review 10.  A role for estriol in human labor, term and preterm.

Authors:  T M Goodwin
Journal:  Am J Obstet Gynecol       Date:  1999-01       Impact factor: 8.661

View more
  5 in total

1.  Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.

Authors:  Camilla Sköld; Tone Bjørge; Anders Ekbom; Anders Engeland; Mika Gissler; Tom Grotmol; Laura Madanat-Harjuoja; Anne Gulbech Ording; Olof Stephansson; Britton Trabert; Steinar Tretli; Rebecca Troisi; Henrik Toft Sørensen; Ingrid Glimelius
Journal:  Int J Cancer       Date:  2018-07-10       Impact factor: 7.396

Review 2.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

3.  Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset.

Authors:  Sven Cnattingius; Sandra Eloranta; Hans-Olov Adami; Ove Axelsson; Paul W Dickman; Chung-cheng Hsieh; Lorelei A Mucci; Dimitrios Trichopoulos; Mats Lambe; Anna L V Johansson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 4.  The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence.

Authors:  R Troisi; T Bjørge; M Gissler; T Grotmol; C M Kitahara; S M Myrtveit Saether; A G Ording; C Sköld; H T Sørensen; B Trabert; I Glimelius
Journal:  J Intern Med       Date:  2018-03-25       Impact factor: 8.989

5.  Cancer risk in mothers of men operated for undescended testis.

Authors:  Hadriano M Lacerda; Lorenzo Richiardi; Andreas Pettersson; Marine Corbin; Franco Merletti; Olof Akre
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.